Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2017 |
26 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2017 |
21 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2017 |
3,775 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2017 |
2,182 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2017 |
6,669 |
HTS_TST |
Service Delivery Point (Community): Other |
2017 |
5,546 |
HTS_TST |
Service Delivery Point (Facility): VCT |
2017 |
723 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2017 |
47 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2017 |
5,957 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2017 |
6,004 |
HTS_TST_POS |
Test Result by Aggregated Age and Sex: Positive <15 Female |
2017 |
3 |
HTS_TST_POS |
Test Result by Aggregated Age and Sex: Positive <15 Male |
2017 |
2 |
HTS_TST_POS |
Test Result by Aggregated Age and Sex: Positive 15+ Female |
2017 |
430 |
HTS_TST_POS |
Test Result by Aggregated Age and Sex: Positive 15+ Male |
2017 |
232 |
KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2017 |
8,000 |
KP_PREV |
By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2017 |
550 |
KP_PREV |
By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2017 |
250 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2017 |
8,800 |
KP_PREV |
Total estimated number of key population in the catchment area |
2017 |
176,000 |
KP_PREV_den |
By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) |
2017 |
160,000 |
KP_PREV_den |
By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) |
2017 |
11,000 |
KP_PREV_den |
By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area |
2017 |
5,000 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2017 |
255 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2017 |
45 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2017 |
300 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2017 |
300 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2017 |
300 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2017 |
255 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2017 |
45 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2017 |
300 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2017 |
300 |
TX_PVLS |
Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months |
2017 |
210 |
TX_PVLS |
Numerator Aggregated Age/Sex: 15+ Female |
2017 |
178 |
TX_PVLS |
Numerator Aggregated Age/Sex: 15+ Male |
2017 |
32 |
TX_PVLS |
Numerator: Indication: Routine |
2017 |
105 |
TX_PVLS |
Numerator: Indication: Targeted |
2017 |
105 |
TX_RET |
Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2017 |
222 |
TX_RET |
Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2017 |
32 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2017 |
264 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2017 |
300 |
TX_RET_den |
Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2017 |
255 |
TX_RET_den |
Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2017 |
45 |